Back to search

From the notice

UPDATE: 10/21/2026 The Government received several questions in the RFI submissions. The attachment labeled “RFI QA Responses HT940226RFI0255 Supplemental Pilot" is intended to address these questions. The DHA plans to continue gathering market intelligence by meeting with interested vendors. Vendor’s will be expected to address questions regarding their RFI submissions as well as general market intelligence needed by the Government and will be given the opportunity to ask the Government questions. Virtual meetings are anticipated to be held on 19 November 2026. Please email Mr. James Goddard to request a one-on-one meeting. The Defense Health Agency (DHA) is currently in the planning phase for partnering with carriers of supplemental insurance focused on cancer coverage. This Request for Information (RFI) is intended to initiate market research efforts as the Government considers structuring processes to meet Congress’ intent. Section 734 of the National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2026 (Enclosure 1) requires DHA to establish a pilot program not later than September 30, 2027, under which members of the regular component of the Army, Navy, Marine Corps, Air Force, or Space Force and their dependents enrolled in TRICARE may obtain supplemental cancer insurance for noncovered expenses under a fixed indemnity supplemental benefit. The supplemental coverage is intended to provide financial assistance for noncovered expenses related to cancer screening, d

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.